Green Planet Bio Engineering CO LTD

8-K10-Q10-K

Market Movers (8-K)

OTC.Pink
Green Planet Bioengineering announces the resignation of Assurance Dimensions as its independent auditor and the engagement of Stephano Slack LLC as the new auditor for the fiscal year ending December 31, 2025.

Quarterly Earnings (10-Q)

See all →
OTC.Pink
Green Planet Bioengineering Co., Ltd. filed its Q2 2026 10-Q, reporting continued shell corporation status with no active business operations and reliance on related party financing.
OTC.Pink
Green Planet Bioengineering Co., Ltd. reports continued operational inactivity and reliance on related party funding for Q1 2026, with a net loss of $10,944.
Delay expected
Worse than expected
OTC.Pink
Green Planet Bioengineering Co., Ltd. filed its Q3 2025 10-Q, reporting continued net losses and a significant working capital deficit as a non-operating shell company.
Delay expected
Worse than expected
Capital raise
OTC.Pink
Green Planet Bioengineering reports continued shell corporation status with no active operations and a significant accumulated deficit, raising going concern doubts.
Worse than expected
Capital raise
Delay expected
OTC.Pink
Green Planet Bioengineering Co., Ltd. reports a net loss of $6,840 for the quarter ended March 31, 2025, with continued reliance on related party funding and no active business operations.
Worse than expected
OTC.Pink
Green Planet Bioengineering Co., Ltd. reports minimal activity and a net loss for the third quarter of 2024, with continued reliance on related party funding and going concern doubts.
Worse than expected

Annual Reports (10-K)

OTC.Pink
Green Planet Bioengineering Co., Ltd. filed its 2025 10-K, confirming its status as a public reorganized shell corporation with no active business operations and ongoing reliance on related party funding.
Capital raise
Delay expected
OTC.Pink
Green Planet Bioengineering Co., Ltd., a public reorganized shell corporation, reports its financial results for the year ended December 31, 2024, with no operating revenues and continued reliance on related party funding.
Delay expected
Worse than expected
OTC.Pink
Green Planet Bioengineering Co., Ltd., a public reorganized shell corporation, reported its 2023 financial results, highlighting no operating revenue and ongoing reliance on related party funding, raising concerns about its ability to continue as a going concern.
Worse than expected